STEPHANIE GARCIA: Open Payments
NPI 1396974408 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 5 payments from 5 companies in 2025. Trend: 2023 $128 · 2024 $152 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $132 |
| Otsuka America Pharmaceutical, Inc. | 1 | $116 |
| ACADIA Pharmaceuticals Inc | 1 | $102 |
| Abbott Laboratories | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: INGREZZA, REXULTI, NUPLAZID, ETERNA, TAKHZYRO.
Industry payments across KS — which companies pay providers there.
